Ocular Therapeutix™ Reports Second Quarter 2018 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
Ocular Therapeutix (OCUL) Tops Q2 EPS by 1c
August 7, 2018 4:01 PM EDTOcular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.37), $0.01 better than the analyst estimate of ($0.38).
We are encouraged with our progress through the first half of 2018, said Antony Mattessich, President and Chief Executive Officer. The on-time resubmission and establishment of a December 28th PDUFA date for... More
